Cargando…

Treatment for non-small-cell lung cancer and circulating tumor cells

Surgery is the main curative therapy for patients with localized non-small-cell lung cancer while radiotherapy (RT), alone or with concurrent platinum-based chemotherapy, remains the primary curative modality for locoregionally advanced non-small-cell lung cancer. The risk of distant metastasis is h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mason, Joel, Blyth, Benjamin, MacManus, Michael P, Martin, Olga A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2017
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310303/ https://www.ncbi.nlm.nih.gov/pubmed/30643579 http://dx.doi.org/10.2217/lmt-2017-0019

Ejemplares similares

A Pattern of Early Radiation-Induced Inflammatory Cytokine Expression Is Associated with Lung Toxicity in Patients with Non-Small Cell Lung Cancer
por: Siva, Shankar, et al.
Publicado: (2014)

Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC
por: MacManus, Michael, et al.
Publicado: (2023)

A prospective observational study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer
por: Siva, Shankar, et al.
Publicado: (2014)

Single-arm prospective interventional study assessing feasibility of using gallium-68 ventilation and perfusion PET/CT to avoid functional lung in patients with stage III non-small cell lung cancer
por: Bucknell, Nicholas, et al.
Publicado: (2020)

Dynamic Thromboembolic Risk Modelling to Target Appropriate Preventative Strategies for Patients with Non-Small Cell Lung Cancer
por: Alexander, Marliese, et al.
Publicado: (2019)

Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancer
por: Alexander, Marliese, et al.
Publicado: (2017)

Absence of a Relationship between Tumor (18)F-fluorodeoxyglucose Standardized Uptake Value and Survival in Patients Treated with Definitive Radiotherapy for Non–Small-Cell Lung Cancer
por: Lin, Ming-Yin, et al.
Publicado: (2014)

Plasticity of circulating tumor cells in small cell lung cancer
por: Seo, Jiyoun, et al.
Publicado: (2023)

Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy
por: Wen, Shu Wen, et al.
Publicado: (2015)

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2015)

Progress and application of circulating tumor cells in non-small cell lung cancer
por: Qian, Huizhu, et al.
Publicado: (2021)

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV
por: Akamatsu, Hiroaki, et al.
Publicado: (2019)

Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned
por: Lee, Dae Ho, et al.
Publicado: (2015)

Robust, independent and relevant prognostic (18)F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?
por: Konert, Tom, et al.
Publicado: (2020)

Circulating Tumor Cells and the Non-Touch Isolation Technique in Surgery for Non-Small-Cell Lung Cancer
por: Adachi, Hiroyuki, et al.
Publicado: (2022)

Dynamic circulating tumor DNA quantificaton for the individualization of non-small-cell lung cancer patients treatment
por: Provencio, Mariano, et al.
Publicado: (2017)

Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer
por: Fang, Xiaoxu, et al.
Publicado: (2022)

Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer
por: Liu, Xingyuan, et al.
Publicado: (2019)

Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients
por: Roumeliotou, Argyro, et al.
Publicado: (2022)

Clinical Utility of Circulating Tumor Cells in ALK-Positive Non-Small-Cell Lung Cancer
por: Faugeroux, Vincent, et al.
Publicado: (2014)

The prognostic significance of circulating tumor cells in head and neck and non‐small‐cell lung cancer
por: Kulasinghe, Arutha, et al.
Publicado: (2018)

Pure Solid Pattern of Non-Small Cell Lung Cancer and Clustered Circulating Tumor Cells
por: Sawabata, Noriyoshi, et al.
Publicado: (2022)

Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer
por: Obermayr, Eva, et al.
Publicado: (2021)

An epithelial-to-mesenchymal transition induced extracellular vesicle prognostic signature in non-small cell lung cancer
por: Lobb, Richard J., et al.
Publicado: (2023)

Association between radiation pneumonitis and tumor response in patients with NSCLC treated with chemoradiation
por: MacManus, Michael P, et al.
Publicado: (2014)

Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer
por: Nadal, Ernest, et al.
Publicado: (2023)

Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer
por: Yao, Yu, et al.
Publicado: (2016)

Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
por: Yang, Jialiang, et al.
Publicado: (2021)

Monitoring Circulating Tumor DNA in Untreated Non-Small-Cell Lung Cancer Patients
por: Ryu, Woo Kyung, et al.
Publicado: (2022)

Impact of Clinical Practice Gaps on the Implementation of Personalized Medicine in Advanced Non–Small-Cell Lung Cancer
por: Sadik, Helen, et al.
Publicado: (2022)

Quantification of Rare Circulating Tumor Cells in Non-Small Cell Lung Cancer by Ligand-Targeted PCR
por: Lou, Jiatao, et al.
Publicado: (2013)

Prognostic significance of circulating tumor cells in non-small cell lung cancer patients undergoing chemotherapy
por: Tong, Bing, et al.
Publicado: (2017)

The prognostic roles of circulating ALDH1(+) tumor cell in the patients with non-small cell lung cancer
por: Tian, Shuang, et al.
Publicado: (2018)

Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer
por: Shishido, Stephanie N., et al.
Publicado: (2019)

Isolation of circulating tumor cells and detection of EGFR mutations in patients with non-small-cell lung cancer
por: Zhang, Qi, et al.
Publicado: (2019)

Microsieves for the detection of circulating tumor cells in leukapheresis product in non-small cell lung cancer patients
por: Tamminga, Menno, et al.
Publicado: (2020)

Circulating tumor cell methylation profiles reveal the classification and evolution of non-small cell lung cancer
por: Jiang, Jia-Hao, et al.
Publicado: (2022)

Analysis of Circulating Tumor and Cancer Stem Cells Provides New Opportunities in Diagnosis and Treatment of Small Cell Lung Cancer
por: Skurikhin, Evgenii G., et al.
Publicado: (2022)

Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA
por: Yaung, Stephanie J., et al.
Publicado: (2022)

Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab
por: Alama, Angela, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i32mdmsbqr1ovpks56hvvgjrln